Stock Updates

Today’s Large Cap Details for Novo Nordisk A/S (NYSE: NVO) of Drug Manufacturers – Other

Novo Nordisk A/S (NYSE: NVO), is firmly in the large market cap category with market cap of 85.39 B. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Novo Nordisk A/S is 43.68 (with a change from open of 0.81%), this in conjunction with a target price of 36.7. Volume today has so far reached 1709658, with an average volume of about 2303.25. The GAP for this stock, is 0.30%.

The P/E ratio is 19.02, bringing the forward P/E to a value of 17.47. The current EPS for Novo Nordisk A/S, is 2.3, with a EPS growth for this year coming to a value of 10.60%. Performance has been interesting with performance year to date coming to 21.81%.

Looking further into the growth statistics for Novo Nordisk A/S, EPS is looking like it will grow 10.66% in the next year. Looking even further it is projected to be 9.50%. Quarter over quarter is 9.60% for EPS growth and for sales growth quarter over quarter it is 4.60%. Looking at past EPS growth statistics we see that for the past five years it has been 20.10%. Sales growth for the past five years has in fact been 11.00%.

Looking at the ownership, we see that the insider ownership is at 26.40% and institutional ownership is 8.50%. Shares outstanding is 1954.94, while shares float is at a value of 1304.81. Float short for Novo Nordisk A/S is 0.33% and the short ratio is 1.84.

In terms of debt, long term debt/equity is 0, while the total debt/equity comes to 0.02. The ability to meet these debts, means that the current ratio is 1.1, and the quick ratio is 0.8. The most recent gross margin is 84.80% and their operating margin is 43.90%. The profit margin is 34.20%.

Novo Nordisk A/S has seen returns on assets of 42.10%, and on investment, 84.70%. Return on equity is 91.20%. Price/Earnings to growth ratio is 2. Price/Sales ratio is at a value of 5.04, with Price/book ratio coming to 18.05 and Price/cash is 32.06, and finally Price/Free cash Flow is 22.74.

The simple moving averages are 2.44% and 15.79% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -23.92% and the 52 week low is 41.40%.

Novo Nordisk A/S has a dividend yield of 2.56%, with a current price of 43.68. The ability to pay this means the payout ratio is 44.10%. This is in an industry, Drug Manufacturers – Other, with equally high dividends from other companies in this sector, which it is Healthcare. Novo Nordisk A/S is based in Denmark.

Performance in the Drug Manufacturers – Other industry means that Novo Nordisk A/S has seen performance for the past week of 0.48%, with performance for the month coming to 8.01%. Looking at the data for the quarter it is at a value of 27.61%, and for the half year the performance is -14.87%. Volatility for this week is 1.14% and for the month this is 0.97%.

NVO

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment